Juliet Redhouse

Juliet is experienced in examination and opposition proceedings at the European Patent Office (EPO), as well as drafting, prosecution and management of global patent portfolios. She also advises clients on infringement, validity and freedom to operate matters. Juliet works in the fields of molecular biology, pharmaceuticals and biotechnology, and has particular experience in the areas of antibody technology, vaccine technology, protein and peptide based medicines, personalised medicine, recombinant gene expression and diagnostic assays.

Juliet graduated from the University of Cambridge with a first class honours degree in natural sciences, specialising in genetics. She went on to obtain a PhD in molecular genetics from the same university. During her PhD, Juliet studied the role of nuclear organisation in the regulation of gene expression through the use of immunoassays, fluorescent in situ hybridisation, confocal microscopy, bioinformatics and traditional genetics techniques.

Juliet is a fellow of the Chartered Institute of Patent Attorneys (CIPA) and European Patent Institute (EPI).